Danaher Posts Fall in 1Q Earnings, Continues to Expects Lower Annual Sales
By Robb M. Stewart
Danaher continues to expect underlying sales will fall this year, though it said it had a good start to the year with improving order trends in its bioprocessing business.
The health-care and laboratory-supply company posted first-quarter earnings for the quarter ended Dec. 31 of $1.09 billion, or $1.45 a share, down from $1.45 billion, or $2.65 a share, a year earlier.
Excluding certain one-off items, Danaher logged adjusted earnings from continuing operations of $1.92 a share, beating the average Wall Street estimate of $1.72 a share
Sales for the first three months of the year fell 2.6% to $5.80 billion, but surpassed the $5.62 billion analysts expected.
For the second quarter, Danaher expects core revenue before items will be down mid-single digits on the same period last year. Full-year core sales are still expected to be down low-single digits, it said.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
April 23, 2024 06:46 ET (10:46 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations